The Past and Future of Biomarkers in Testicular Germ Cell Tumors

Volume: 1, Issue: 1, Pages: 77 - 84
Published: Oct 13, 2020
Abstract
Testicular germ cell tumor (GCT) is the most common malignancy in 18- to 40-year-old men. Unlike most other cancers, GCT is frequently curable even when metastatic. These tumors can be classified histologically into seminoma and non-seminoma, which determines treatment. Therefore, successful treatment requires accurate diagnosis, classification, and monitoring. Serum tumor markers, including lactate dehydrogenase, α-fetoprotein, and β-human...
Paper Details
Title
The Past and Future of Biomarkers in Testicular Germ Cell Tumors
Published Date
Oct 13, 2020
Volume
1
Issue
1
Pages
77 - 84
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.